Evidence map›Paper›PMID 35568189›Full record

ReviewAmerican journal of obstetrics and gynecology2022

COVID-19 vaccination in pregnancy.

Erkan Kalafat, Paul Heath, Smriti Prasad, Pat O Brien, Asma Khalil

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of obstetrics and gynecology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Pathogenesis of viral infections during pregnancy.Clinical microbiology reviews · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Maternal and perinatal outcomes of COVID-19 vaccination during pregnancy.Journal of the Turkish German Gynecological Association · 2023
    Article
  14. Article
  15. Article
  16. An Update on COVID-19 Vaccination and Pregnancy.Journal of personalized medicine · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Erkan KalafatDepartment of Obstetrics and Gynecology, School of Medicine, Koc University, Istanbul, Turkey.
Paul HeathPediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London, England, United Kingdom.
Smriti PrasadFetal Medicine Unit, St George's Hospital, St George's University of London, London, England, United Kingdom.
Pat O BrienInstitute for Women's Health, University College London Hospitals, London, England, United Kingdom; Royal College of Obstetricians and Gynaecologists, London, England, United Kingdom.
Asma KhalilFetal Medicine Unit, St George's Hospital, St George's University of London, London, England, United Kingdom; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University Hospitals NHS Foundation Trust, St George's University of London, London, England, United Kingdom; Liverpool Women's Hospital, Liverpool, United Kingdom. Electronic address: akhalil@sgul.ac.uk.
St George's, University of London · GBKoç University · TRRoyal College of Obstetricians and Gynaecologists · GBUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite a recent endorsement from official and professional bodies unequivocally recommending COVID-19 vaccination, vaccine hesitancy among pregnant people remains high. The accumulated evidence demonstrates that pregnant people are a special risk group for COVID-19, with an increased risk of intensive care unit admission, extracorporeal membranous oxygenation requirement, preterm birth, and perinatal death. These risks are further increased with some variants of concern, and vaccination of pregnant people reduces the COVID-19-related increase in maternal or fetal morbidity. Data from more than 180,000 vaccinated persons show that immunization against COVID-19 with an mRNA vaccine is safe for pregnant people. Many observational studies comparing perinatal outcomes between vaccinated and unvaccinated pregnant people have had reassuring findings and did not demonstrate harmful effects on pregnancy or the newborn. Immunization with mRNA vaccines does not increase the risk of miscarriage, preterm delivery, low birthweight, maternal or neonatal intensive care unit admission, fetal death, fetal abnormality, or pulmonary embolism. Moreover, observational data corroborate the findings of randomized trials that mRNA vaccination is highly effective at preventing severe SARS-CoV-2 infection in pregnant people, emphasizing that the potential maternal and fetal benefits of vaccination greatly outweigh the potential risks of vaccination. Ensuring pregnant people have unrestricted access to COVID-19 vaccination should be a priority in every country worldwide.

Indexed as

COVID-19COVID-19 VaccinesPregnancy Complications, InfectiousPremature BirthFemaleHumansInfant, NewbornmRNA VaccinesPregnancySARS-CoV-2VaccinationVaccines, SyntheticCOVID-19 VaccinesmRNA VaccinesVaccines, SyntheticantibodiesCOVID-19immunogenicitymaternal immunizationpandemicpregnancyreactogenicitySARS-CoV-2side effectsvaccine

Identifiers

PMID35568189
PMCPMC9093065
OpenAlexW4280518016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.